Rapid Dissolving Tablet (RDT)
Desira
Central Neuro-Arousal & Intimacy Synergy (Sublingual Tablet)
From $79/mo
Physician-directed women's protocol
Desira: Dual-Pathway Female Libido & Arousal Protocol.
Sublingual Oxytocin and Bremelanotide (PT-141) calibrated for intimacy, connection, and rapid neural responsiveness.
How the formulation works
Bremelanotide (PT-141) acts on central melanocortin receptors to raise desire itself rather than waiting on a vascular response, while Oxytocin supports the prosocial bonding and emotional closeness side of intimacy. Held under the tongue, both bypass the gut for a faster, more predictable onset.
NEUROCHEMICAL BALANCE
Reignite natural responsiveness and vitality.
A targeted sublingual compound designed to modulate pathways supporting intimacy, energy, and hormonal harmony.
Matched to your protocol
One physician-directed formulation for this indication.
Why this protocol
Two pathways in one tablet: central arousal signaling from PT-141 and the intimacy and bonding effect of Oxytocin — without a vascular crash afterwards.
Clinical standards
503B cGMP inspected
Every batch potency-tested by HPLC.
US licensed MDs
Physician review before any protocol ships.
Doctor refund guarantee
Not eligible? You are refunded in full.
Discreet unmarked packaging
Plain outer box, no clinical branding.
Common questions
Place one tablet under the tongue 30-45 minutes ahead and let it dissolve fully. Peak central response lands around 60-120 minutes and responsiveness typically carries 12-24 hours.
No. Desira leads with the central arousal and bonding pathway rather than PDE5 blood-flow support, and the dosing is set for female physiology.
Usually yes, but your physician reviews your full medication list, blood pressure and cardiovascular history during intake and declines the protocol if there is any risk. Not for use during pregnancy or breastfeeding.
Ready to see what you qualify for?
The intake takes about three minutes. A licensed physician reviews it before anything ships.
Start clinical intake